Kbc Group Nv Repligen Corp Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Repligen Corp stock. As of the latest transaction made, Kbc Group Nv holds 2,969 shares of RGEN stock, worth $436,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,969

Previous 8,452 64.87%

Holding current value

$436,294

Previous $1.07 Million 58.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$119.79 - $167.35 $656,808 - $917,580	-5,483 Reduced 64.87%	2,969 $442,000
Q2 2024 Jul 17, 2024	BUY	$120.0 - $182.95 $7,920 - $12,074	66 Added 0.79%	8,452 $1.07 Million
Q1 2024 May 08, 2024	BUY	$170.78 - $208.42 $37,400 - $45,643	219 Added 2.68%	8,386 $1.54 Million
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $1.41 Million - $2.29 Million	-12,336 Reduced 60.17%	8,167 $1.47 Million
Q3 2023 Feb 15, 2024	BUY	$138.78 - $176.51 $2.68 Million - $3.41 Million	19,318 Added 91.84%	40,352 $6.42 Million
Q2 2023 Feb 15, 2024	BUY	$138.42 - $180.31 $1.78 Million - $2.32 Million	12,867 Added 157.55%	21,034 $2.98 Million
Q2 2023 Jul 28, 2023	BUY	$138.42 - $180.31 $2.84 Million - $3.7 Million	20,503 New	20,503 $2.9 Million
Q1 2023 Feb 14, 2024	BUY	$154.26 - $198.1 $2.38 Million - $3.06 Million	15,425 Added 446.84%	18,877 $3.18 Million
Q4 2022 Feb 14, 2024	SELL	$162.42 - $220.56 $765,810 - $1.04 Million	-4,715 Reduced 57.73%	3,452 $585,000
Q4 2019 Feb 11, 2020	SELL	$73.84 - $93.08 $2.28 Million - $2.88 Million	-30,929 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$76.65 - $95.51 $1.04 Million - $1.3 Million	13,617 Added 78.66%	30,929 $2.37 Million
Q1 2019 May 10, 2019	BUY	$49.45 - $62.8 $856,078 - $1.09 Million	17,312 New	17,312 $0

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account